Global Custom Market Research Reports Provider Company

phone

Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America
Summary

Karyopharm Therapeutics Inc (Karyopharm Therapeutics) is a clinical-stage pharmaceutical company that discovers and develops novel drugs for the treatment of cancer and other diseases. The company develops small molecule selective inhibitor of nuclear export compounds that inhibit the nuclear export protein XPO1. Its pipeline drug candidates include oral selinexor, oral verdinexor, oral KPT-350, oral KPT-8602 and oral KPT-9274. Karyopharm Therapeutics drug candidates are indicated for the treatment of various hematological and solid tumor malignancies including multiple myeloma, acute myeloid leukemia, diffuse large B-cell lymphoma, liposarcoma, glioblastoma and gynecological malignancies. The company operates across the US and Germany. Karyopharm Therapeutics is headquartered in Newton, Massachusetts, the US.

Karyopharm Therapeutics Inc Key Recent Developments

Nov 02,2017: Karyopharm Reports Third Quarter 2017 Financial Results and Highlights Recent Progress
Sep 12,2017: Karyopharm Appoints Michael Falvey as Chief Financial Officer, Adds New Clinical Strategy and Human Resources Executives and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Aug 08,2017: Karyopharm Reports Second Quarter 2017 Financial Results and Highlights Recent Progress
May 04,2017: Karyopharm Reports First Quarter 2017 Financial Results and Highlights Recent Progress
Apr 03,2017: Karyopharm Announces Management Change

This comprehensive SWOT profile of Karyopharm Therapeutics Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Karyopharm Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Karyopharm Therapeutics Inc - Key Information

Karyopharm Therapeutics Inc - Overview

Karyopharm Therapeutics Inc - Key Employees

Karyopharm Therapeutics Inc - Key Employee Biographies

Karyopharm Therapeutics Inc - Key Operational Heads

Karyopharm Therapeutics Inc - Major Products and Services

Karyopharm Therapeutics Inc - History

Karyopharm Therapeutics Inc - Company Statement

Karyopharm Therapeutics Inc - Locations And Subsidiaries

Karyopharm Therapeutics Inc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Karyopharm Therapeutics Inc - Business Description

Karyopharm Therapeutics Inc - Corporate Strategy

Karyopharm Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Karyopharm Therapeutics Inc - Strengths

Karyopharm Therapeutics Inc - Weaknesses

Karyopharm Therapeutics Inc - Opportunities

Karyopharm Therapeutics Inc - Threats

Karyopharm Therapeutics Inc - Key Competitors



Section 3 - Company Financial Performance Charts



Karyopharm Therapeutics Inc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Karyopharm Therapeutics Inc, Key Information

Karyopharm Therapeutics Inc, Key Ratios

Karyopharm Therapeutics Inc, Share Data

Karyopharm Therapeutics Inc, Major Products and Services

Karyopharm Therapeutics Inc, History

Karyopharm Therapeutics Inc, Key Employees

Karyopharm Therapeutics Inc, Key Employee Biographies

Karyopharm Therapeutics Inc, Key Operational Heads

Karyopharm Therapeutics Inc, Other Locations

Karyopharm Therapeutics Inc, Subsidiaries

Karyopharm Therapeutics Inc, Key Manufacturing facilities

Karyopharm Therapeutics Inc, Key Competitors

Karyopharm Therapeutics Inc, SWOT Analysis

Karyopharm Therapeutics Inc, Ratios based on current share price

Karyopharm Therapeutics Inc, Annual Ratios

Karyopharm Therapeutics Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Karyopharm Therapeutics Inc, Performance Chart

Karyopharm Therapeutics Inc, Ratio Charts

Karyopharm Therapeutics Inc (Karyopharm Therapeutics) is a clinical-stage pharmaceutical company that discovers and develops novel drugs for the treatment of cancer and other diseases. The company develops small molecule selective

View Report

Karyopharm Therapeutics Inc (Karyopharm Therapeutics) is a clinical-stage pharmaceutical company that discovers and develops novel drugs for the treatment of cancer and other diseases. The company develops small molecule selective

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports